R

Redmile Group, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Redmile Group, LLC with $1.0B in long positions as of Q3 2025, 98% allocated to Healthcare, and 69% concentrated in top 10 positions.

Portfolio Value
$1.0B
Top 10 Concentration
69%
Top Sector
Healthcare (98%)
US Exposure
82%
Market Cap Focus
Small Cap
Countries
6

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 98.40%Healthcare
Healthcare
98.40%

Industry Breakdown

2 industries across all sectors

Biotechnology: 93.13%BiotechnologyMedical - Devices: 5.24%
Biotechnology
Healthcare
93.13%
Medical - Devices
Healthcare
5.24%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 44.71%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 46.42%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 7.38%Nano Cap (< $50M): 0.39%N/A (ETF or Unknown): 1.09%
Mid Cap ($2B - $10B)
44.71%
Small Cap ($300M - $2B)
46.42%
Micro Cap ($50M - $300M)
7.38%
Nano Cap (< $50M)
0.39%
N/A (ETF or Unknown)
1.09%

Portfolio Concentration

Top 10 Holdings %
68.92%
Top 20 Holdings %
90.11%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
81.92%
International
18.08%
Countries
6
Largest Int'l Market
Canada - 6.43%
United States of America
81.92% ($842.0M)
34 holdings
Canada
6.43% ($66.1M)
2 holdings
Switzerland
6.10% ($62.7M)
1 holdings
United Kingdom
4.72% ($48.5M)
1 holdings
Costa Rica
0.52% ($5.3M)
1 holdings
Netherlands
0.31% ($3.2M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
22.8 quarters
Avg. Top 20
19.7 quarters
Avg. All Positions
18.3 quarters
Median Holding Period
18.5 quarters
Persistence Rate
92.5%
Persistent Holdings Weight
98.33%
Persistent Positions
37
Longest Held
Amicus Therapeutics, Inc logo
Amicus Therapeutics, IncFOLD - 50 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
2.50%
Largest Position
Scholar Rock Holding Corporation Common Stock logo
Scholar Rock Holding Corporation Common StockSRRK - 14.15%
Largest Ownership Stake
ADC Therapeutics SA logo
ADC Therapeutics SAADCT - 13.93%
Avg. Ownership Stake
4.86%
Ownership Stake >5%
12
Ownership Stake >1%
27

Historical (Since Q1 2013)

Avg. New Position
2.07%
Avg. Ownership Stake
5.33%
Largest Position
Fate Therapeutics, Inc. logo
Fate Therapeutics, Inc.FATE - 21.39% (Q4 2021)
Largest Ownership Stake
Augmedix, Inc. Common Stock logo
Augmedix, Inc. Common StockAUGX - 38.70% (Q4 2021)

Portfolio Turnover

Current Quarter

Turnover Ratio
7.4%
Value Traded
$75.72M
Positions Added
0
Positions Exited
8

Historical (Since Q1 2013)

Avg. Turnover Ratio
23.0%
Avg. Positions Added
10
Avg. Positions Exited
12
Highest Turnover
59.4%
Q3 2014
Lowest Turnover
4.5%
Q1 2022

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.